Back
ProShares UltraShort Nasdaq Biotech Vs. Axon Enterprise Industry Stock Comparison
Sell
25
BIS
ProShares UltraShort Nasdaq Biotech
Last Price:
15.25
Seasonality Move:
-11.25%
Buy
99
AXON
Axon Enterprise
Last Price:
595.25
Seasonality Move:
18.01%
Sell
25
ProShares UltraShort Nasdaq Biotech (BIS)
is a Sell
Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?
- The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $14.43. The Score for BIS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- BIS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
99
Axon Enterprise (AXON)
is a Buy
Is Axon Enterprise a Buy, Sell or Hold?
- The current Axon Enterprise [AXON] share price is $616.14. The Score for AXON is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- AXON is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
BIS Stock Price Chart
What is ProShares UltraShort Nasdaq Biotech's stock price today?
-
The ProShares UltraShort Nasdaq Biotech share price today is $14.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
AXON Stock Price Chart
What is Axon Enterprise's stock price today?
-
The Axon Enterprise share price today is $616.14
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXON is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 38.13 | Sell |
| Chaikin Money Flow: | 13900 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.74 - 15.6) | Sell |
| Bollinger Bands (100): | (14.54 - 15.96) | Sell |
AXON Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 33.5 | Buy |
| Relative Strength Index (14 RSI): | 91.12 | Buy |
| Chaikin Money Flow: | 943961 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (404.66 - 500.1) | Buy |
| Bollinger Bands (100): | (307.31 - 434.07) | Buy |
BIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.05 | Sell |
| 20-day SMA: | 15.12 | Sell |
| 50-day SMA: | 15.11 | Sell |
| 200-day SMA: | 16.68 | Sell |
| 8-day EMA: | 14.85 | Sell |
| 20-day EMA: | 15.07 | Sell |
| 50-day EMA: | 15.18 | Sell |
| 200-day EMA: | 16.65 | Sell |
AXON Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 483.83 | Buy |
| 20-day SMA: | 458.3 | Buy |
| 50-day SMA: | 417.81 | Buy |
| 200-day SMA: | 332.5 | Buy |
| 8-day EMA: | 511.84 | Buy |
| 20-day EMA: | 468.72 | Buy |
| 50-day EMA: | 426.74 | Buy |
| 200-day EMA: | 342.79 | Buy |
ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Axon Enterprise Earnings Growth & AXON Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.32 per share, and an increase next year of $1.00 per share.
ProShares UltraShort Nasdaq Biotech Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axon Enterprise Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||